Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.

Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.

PMID:
23069872
2.

Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Mattsson N, Olsson M, Gustavsson MK, Kosicek M, Malnar M, Månsson JE, Blomqvist M, Gobom J, Andreasson U, Brinkmalm G, Vite C, Hecimovic S, Hastings C, Blennow K, Zetterberg H, Portelius E.

Metab Brain Dis. 2012 Dec;27(4):573-85. doi: 10.1007/s11011-012-9332-8. Epub 2012 Sep 1.

PMID:
22935999
3.

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.

Brinkmalm G, Brinkmalm A, Bourgeois P, Persson R, Hansson O, Portelius E, Mercken M, Andreasson U, Parent S, Lipari F, Ohrfelt A, Bjerke M, Minthon L, Zetterberg H, Blennow K, Nutu M.

Brain Res. 2013 Jun 4;1513:117-26. doi: 10.1016/j.brainres.2013.03.019. Epub 2013 Mar 27.

PMID:
23541617
4.

An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.

Brinkmalm G, Portelius E, Öhrfelt A, Mattsson N, Persson R, Gustavsson MK, Vite CH, Gobom J, Månsson JE, Nilsson J, Halim A, Larson G, Rüetschi U, Zetterberg H, Blennow K, Brinkmalm A.

J Mass Spectrom. 2012 May;47(5):591-603. doi: 10.1002/jms.2987.

PMID:
22576872
5.

Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1 inhibition in a dog model.

Borghys H, Jacobs T, Van Broeck B, Dillen L, Dhuyvetter D, Gijsen H, Mercken M.

J Alzheimers Dis. 2014;38(1):39-48. doi: 10.3233/JAD-130599.

PMID:
23948925
6.

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome.

Portelius E, Hölttä M, Soininen H, Bjerke M, Zetterberg H, Westerlund A, Herukka SK, Blennow K, Mattsson N.

Neuromolecular Med. 2014 Jun;16(2):510-6. doi: 10.1007/s12017-014-8302-1. Epub 2014 Apr 18.

PMID:
24740518
7.

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.

Ottervald J, Franzén B, Nilsson K, Andersson LI, Khademi M, Eriksson B, Kjellström S, Marko-Varga G, Végvári A, Harris RA, Laurell T, Miliotis T, Matusevicius D, Salter H, Ferm M, Olsson T.

J Proteomics. 2010 Apr 18;73(6):1117-32. doi: 10.1016/j.jprot.2010.01.004. Epub 2010 Jan 20.

PMID:
20093204
8.

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid.

Portelius E, Brinkmalm G, Tran A, Andreasson U, Zetterberg H, Westman-Brinkmalm A, Blennow K, Ohrfelt A.

Exp Neurol. 2010 Jun;223(2):351-8. doi: 10.1016/j.expneurol.2009.06.011. Epub 2009 Jun 25.

PMID:
19559702
9.

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

Olsson A, Höglund K, Sjögren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Möller HJ, Hampel H, Davidsson P, Blennow K.

Exp Neurol. 2003 Sep;183(1):74-80.

PMID:
12957490
10.
11.

Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.

Rogeberg M, Almdahl IS, Wettergreen M, Nilsson LN, Fladby T.

J Proteome Res. 2015 Nov 6;14(11):4834-43. doi: 10.1021/acs.jproteome.5b00668. Epub 2015 Oct 16.

PMID:
26452689
12.

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism.

Mattsson N, Bremell D, Anckarsäter R, Blennow K, Anckarsäter H, Zetterberg H, Hagberg L.

BMC Neurol. 2010 Jun 22;10:51. doi: 10.1186/1471-2377-10-51.

13.

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.

Portelius E, Brinkmalm G, Tran AJ, Zetterberg H, Westman-Brinkmalm A, Blennow K.

Neurodegener Dis. 2009;6(3):87-94. doi: 10.1159/000203774. Epub 2009 Feb 20.

PMID:
19229112
14.

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.

Romme Christensen J, Börnsen L, Khademi M, Olsson T, Jensen PE, Sørensen PS, Sellebjerg F.

Mult Scler. 2013 Jun;19(7):877-84. doi: 10.1177/1352458512466929. Epub 2012 Nov 24.

PMID:
23178691
15.

Converging pathways of chromogranin and amyloid metabolism in the brain.

Mattsson N, Johansson P, Hansson O, Wallin A, Johansson JO, Andreasson U, Andersen O, Haghighi S, Olsson M, Stridsberg M, Svensson J, Blennow K, Zetterberg H.

J Alzheimers Dis. 2010;20(4):1039-49. doi: 10.3233/JAD-2010-091651. Erratum in: J Alzheimers Dis. 2011;23(4):761.

PMID:
20413871
16.

Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.

Oe T, Ackermann BL, Inoue K, Berna MJ, Garner CO, Gelfanova V, Dean RA, Siemers ER, Holtzman DM, Farlow MR, Blair IA.

Rapid Commun Mass Spectrom. 2006;20(24):3723-35.

PMID:
17117458
17.

Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.

Shahim P, Rejdak R, Ksiazek P, Blennow K, Zetterberg H, Mattsson N, Rejdak K.

Eur J Neurol. 2014 Mar;21(3):486-91. doi: 10.1111/ene.12336. Epub 2013 Dec 26.

PMID:
24372994
18.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
19.

Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.

Elovaara I, Ukkonen M, Leppäkynnäs M, Lehtimäki T, Luomala M, Peltola J, Dastidar P.

Arch Neurol. 2000 Apr;57(4):546-51.

PMID:
10768630
20.

Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients.

Zeman D, Adam P, Kalistová H, Sobek O, Kelbich P, Andel J, Andel M.

Acta Neurol Scand. 2000 Feb;101(2):89-94.

PMID:
10685854

Supplemental Content

Support Center